Self-amplifying RNA (saRNA) Virtual Biotech seeks VC investment to develop a pipeline of RNA therapeutics and vaccines.
We are looking for $6-10 million for pre-series A investment.
Take a look at our prospective
+ Novel self-amplifying RNA (saRNA) Technology Platform.
+ Strong IP position on saRNA Technology Platform and Nanoparticle Delivery Vehicle.
+ This company’s Technology Platform is the “Next Generation” approach for mRNA therapeutics, cancer vaccines and infectious diseases. Multiple gene delivery, can deliver antigen or protein.
+ Superior dosing and production method by virtue of biosynthetic and self-assembling delivery system when compared to current lipid coated mRNA technology.
+ Four (4) Oncology programs are Non-Viral Gene Therapies; Technology Platform is applicable for vaccines and rare diseases too.
+ Demonstration of Technology Platform Process with Proof of Concept Studies.
+ Financing will be utilized for advancement of the oncology pipeline and continuing demonstration of process scalability.
+ This company plans to have multiple assets in the clinic by 2023.
+ Leadership Team with big pharma experience (ex-GSK). Very Strong Scientific Advisory Board. Company is based in northeastern USA.
+ Please request the CIM after Fully Executed NDA.
Private-Equity owned, Phase III plasma-derived therapeutic company is ready to build the commercial facility with One Million Liter annual capacity, in Dallas Texas Looking to Raise Capital
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/Manufacture-icon.png300300Jim Usryhttps://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.pngJim Usry2021-10-19 17:23:522021-10-31 18:01:44Phase III plasma-derived Therapeutic Company Raise Capital
Non-cGMP API Drug Development Starting Materials + API Pilot
Plant and cGMP CDMO: Ready for Immediate Acquisition with operations in Jaipur, India and Birmingham, Alabama
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/Manufacture-icon.png300300Jim Usryhttps://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.pngJim Usry2021-10-19 16:51:242021-10-31 18:02:12Non-cGMP API Starting Material Company Asset Opportunity
We appreciate your interest! Please get in touch and we will contact you directly.
Services and Partnership Opportunities
Pharmaceutical business development
ANDAs for sale
505(b)(2) for sale
Oncology company for sale
Oncology sales force
Pharma distribution deals
Branded generics for sale
Pharmaceutical partnering companies
Pharmaceutical development deals
Pharma commercialization consulting
Head and neck cancer assets available for licensing
Pharmaceutical deal arrangers
Pharma manufacturing facilities finders
Pharmaceutical authorized generic products available
Commercial Healthcare Partners
The information contained in this website is for general information purposes only. The information is provided by Commercial Healthcare Partners and while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.